Invention Grant
- Patent Title: HCV NS3 protease inhibitors
-
Application No.: US12325965Application Date: 2008-12-01
-
Publication No.: US08216999B2Publication Date: 2012-07-10
- Inventor: M. Katharine Holloway , Nigel J. Liverton , Steven W. Ludmerer , John A. McCauley , David B. Olsen , Michael T. Rudd , Joseph P. Vacca , Charles J. McIntyre
- Applicant: M. Katharine Holloway , Nigel J. Liverton , Steven W. Ludmerer , John A. McCauley , David B. Olsen , Michael T. Rudd , Joseph P. Vacca , Charles J. McIntyre
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Julie M. Lake; Sheldon O. Heber
- Main IPC: A61K38/12
- IPC: A61K38/12 ; C07K7/50
Abstract:
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Public/Granted literature
- US20090124661A1 HCV NS3 PROTEASE INHIBITORS Public/Granted day:2009-05-14
Information query
IPC分类:
